Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
46
datasets available to search
ShareScore release 0.9.0
Dataset results
46 results for “First-line Regimen”
Sequential and Concurrent FOLFOXIRI/Bevacizumab Regimens Versus FOLFOX/Bevacizumab in First-Line Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT01765582. IPD Sharing: Not stated. Countries: 1. Publications: 2.
GAD-M Regimen As First-Line Treatment in Untreated Extranodal NK/T Cell Lymphoma
ClinicalTrials.gov study NCT01991158. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase II Study of TX Regimen as First-line Treatment for Asian Elderly Patients With Advanced Adenocarcinoma of Lung
ClinicalTrials.gov study NCT00816868. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Tenofovir Plus Lamivudine Plus Efavirenz Regimen as First-line Antiretroviral Therapy
ClinicalTrials.gov study NCT01844297. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT02767674. IPD Sharing: YES. Countries: 1. Publications: 6.
Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma
ClinicalTrials.gov study NCT02396043. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Orelabrutinib Combined With Obinutuzumab and Lenalidomide (OGL Regimen) as First-line Treatment for Marginal Zone Lymphoma.
ClinicalTrials.gov study NCT06454968. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT05832892. IPD Sharing: NO. Countries: 1. Publications: 0.
Classification by a gene expression profile can help to select oxaliplatin- or irinotecan-based regimen for first-line treatment of metastatic colorectal cancer: Translational research of the TRICOLOR
GEO Series GSE147571. Homo sapiens. 308 samples. Type: Expression profiling by array.
A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT04247984. IPD Sharing: Not stated. Countries: 1. Publications: 0.
First-Line Treatment Induced With mFOLFOX6 and HLX04 Regimen, Following Combined With Serplulimab in MSS Initially Unresectable Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT06491355. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy and Safety of a Sintilimab Plus ICE Regimen Versus ICE Regimen in Classic Hodgkin's Lymphoma Patients (cHL) Who Have Failed First-line Standard Chemotherapy
ClinicalTrials.gov study NCT04044222. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of Orelabrutinib Combined With BG Regimen First-line Treatment of CLL/SLL
ClinicalTrials.gov study NCT05918276. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety Study of a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric Adenocarcinoma
ClinicalTrials.gov study NCT01552980. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ORIENT-31 Regimen in Combination with SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs
ClinicalTrials.gov study NCT06775743. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Cadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT06218810. IPD Sharing: NO. Countries: 1. Publications: 0.
VIC Regimen Versus Bevacizumab Plus Chemotherapy as First-Line Treatment for BRAF V600E-Mutated Advanced Colorectal Cancer
ClinicalTrials.gov study NCT05540951. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Single-arm, Multicenter Exploratory Clinical Trial of Anlotinib Combined With TQB2450 and the SOX Regimen as First-line Treatment for Advanced Gastric Cancer With Low PD-L1 Expression
ClinicalTrials.gov study NCT06939452. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Rituximab-Methotrexate-Temozolomide-Thiotepa (RMTT) Regimen As First-line Therapy for PCNS DLBCL
ClinicalTrials.gov study NCT06832267. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety Study of a Modified XELOX Regimen in First-Line Treatment of Metastatic Colorectal Adenocarcinoma
ClinicalTrials.gov study NCT01552967. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.